Krish W. Ramadurai

Krish W. Ramadurai Email and Phone Number

Partner at AIX Ventures | Author @ AIX Ventures
Krish W. Ramadurai's Location
San Francisco, California, United States, United States
Krish W. Ramadurai's Contact Details

Krish W. Ramadurai personal email

n/a
About Krish W. Ramadurai

Krish is a Partner at AIX Ventures, where he leads the firm's technical due diligence, investment sourcing, and portfolio operational support across their artificial intelligence, healthcare, and life sciences practices. He has led and managed 40+ early and growth stage investments across multiple top-decile performing funds with a cumulative portfolio enterprise value of $10B+ and an extensive track record of success with exits including Volumetric Biotechnologies (Acquired by 3D Systems), PathologyWatch (Acquired by Sonic Healthcare), Trials.AI (Acquired by ZS Associates), and Insilico Medicine (IPO Announced). He has backed over 20 major scientific breakthroughs spanning the world's first AI-designed drug in human trials and the first drug discovered through a 3D bioprinted tissue disease model to the launch of the first commercial rideshare satellite into space. Furthermore, he is a Harvard & Oxford-trained scientist and biomolecular engineer, multi-published author, advisor, lecturer, and former researcher at Harvard & MIT. While at Harvard, he worked with former United States Secretary of Defense Ash Carter and Nobel Laureate Economist Michael Kremer on the United States Agency for International Development (USAID) Development Innovation Ventures Fund and published three internationally-released books on applied engineering and medicine featured in Barnes & Noble and the Oxford, MIT, Harvard, Yale, and Princeton library collections. He has held chairman and board positions for multiple companies and is a venture advisor for Nucleate and the National Venture Capital Association (NVCA) Venture Forward Program, and a member of Oxford University's Institute of Biomedical Engineering (IBME), American Society of Biomechanics (ASB), the American Institute of Chemical Engineers (AIChE), and the Advanced Research Projects Agency for Health (ARPA-H). His thought leadership on AI-enabled life sciences, healthcare, and technology has been featured in leading media outlets, including the Wall Street Journal, Venture Capital Journal, Yahoo Finance, NBC, World Economic Forum, Economy Middle East, TechBullion, Apple Podcasts, Funds Europe Magazine, Pulse 2.0, and Nikkei Asia.

Krish W. Ramadurai's Current Company Details
AIX Ventures

Aix Ventures

View
Partner at AIX Ventures | Author
Krish W. Ramadurai Work Experience Details
  • Aix Ventures
    Partner
    Aix Ventures Aug 2024 - Present
    San Francisco, Us
    Investing at the intersection of Healthcare, Life Sciences, and Artificial Intelligence: https://www.aixventures.com/
  • Vevo Therapeutics
    Investor
    Vevo Therapeutics Aug 2024 - Present
  • Ellipsis Health
    Investor
    Ellipsis Health Aug 2024 - Present
    San Francisco, California, Us
  • Ambience Healthcare
    Investor
    Ambience Healthcare Aug 2024 - Present
    San Francisco, Ca, Us
  • Profluent
    Investor
    Profluent Aug 2024 - Present
    Emeryville, Ca, Us
  • Hugging Face
    Investor
    Hugging Face Aug 2024 - Present
    Us
  • Perplexity
    Investor
    Perplexity Aug 2024 - Present
    San Francisco, California, Us
  • Harvard University
    Guest Lecturer
    Harvard University May 2017 - Present
    Cambridge, Massachusetts, Us
    Invited lecturer in the Faculty of Arts & Sciences for undergraduate and graduate Tissue Engineering for Clinical Applications and Biochemical Engineering & Synthetic Life courses with 25+ lectures given to date
  • Advanced Research Projects Agency For Health (Arpa-H)
    Investor Member
    Advanced Research Projects Agency For Health (Arpa-H) Oct 2024 - Present
    Bethesda, Md, Us
    Investor Catalyst Hub Spoke Member
  • National Venture Capital Association
    Venture Mentor
    National Venture Capital Association Apr 2023 - Present
    Washington, Dc, Us
  • Nucleate
    Venture Advisor
    Nucleate Oct 2021 - Present
    Boston, Us
    Nucleate is dedicated to empowering the next generation of biotech leaders who transform experiments into enterprises
  • Precipoint
    Board Chairman & Investor
    Precipoint Jun 2023 - Aug 2024
    Garching, Bavaria, De
  • Xcures
    Board Observer & Investor
    Xcures Aug 2022 - Aug 2024
    Oakland, California, Us
  • Sorcero
    Board Observer & Investor
    Sorcero Jan 2022 - Aug 2024
    Washington, District Of Columbia, Us
  • Bit.Bio
    Investor
    Bit.Bio Sep 2021 - Aug 2024
    Cambridge, Cambridgeshire, Gb
  • Attivare Therapeutics
    Investor
    Attivare Therapeutics Aug 2021 - Aug 2024
  • Caresyntax
    Investor
    Caresyntax Jul 2021 - Aug 2024
    San Francisco, Ca, Us
  • Loft Orbital
    Investor
    Loft Orbital Jul 2021 - Aug 2024
    San Francisco, Ca, Us
  • Bioz
    Investor
    Bioz Apr 2021 - Aug 2024
    Palo Alto, California, Us
  • Sana Health
    Investor
    Sana Health Apr 2021 - Aug 2024
    Louisville, Colorado, Us
  • Paradromics Inc.
    Investor
    Paradromics Inc. Mar 2021 - Aug 2024
    Austin, Texas, Us
  • Aether
    Investor
    Aether Mar 2021 - Aug 2024
    Menlo Park, California, Us
  • Harmonix Fund
    Partner
    Harmonix Fund Nov 2020 - Aug 2024
    La Quinta, California, Us
    • Managed top-decile performing venture capital fund with a proven track record of 40+ investments in healthcare, life sciences, and deep technology with a cumulative portfolio enterprise valuation of $7B+ across Funds I & II with four exits, including 1 IPO and 3 acquisitions.• Sourced and led due diligence for 30 investments across early and growth stages, composed in-depth investment memorandums for investment committees, and built a multi-stage diligence process and deal assessment framework. • Spearheaded investment practices across life sciences, healthcare, artificial intelligence, and deep technology infrastructure sectors. • Developed a proprietary investment sourcing pipeline of 4,000+ opportunities screened and conducted extensive buy-side market and technical research to develop the firm’s portfolio sector and stage allocation model.• Composed 50+ in-depth investment memorandums for investment committees, conducted quarterly portfolio monitoring and reporting, and led deal negotiations, including structuring, financing, and closing transactions.• Operationally supported 40 portfolio companies with multiple board-level positions and assisted CEOs with $250M+ in capital raises, M&A diligence, technology development, executive hiring, and launching 5+ products to market.
  • Harmonix Fund
    Principal
    Harmonix Fund Sep 2020 - Nov 2020
    La Quinta, California, Us
    • Implemented institutional due diligence process and led investment analysis, technical diligence, and deal sourcing in building top-decile performing Fund I.
  • Harmonix Fund
    Senior Associate
    Harmonix Fund Apr 2020 - Sep 2020
    La Quinta, California, Us
  • Harmonix Fund
    Analyst
    Harmonix Fund Nov 2019 - Apr 2020
    La Quinta, California, Us
  • Qu Biologics Inc.
    Investor
    Qu Biologics Inc. Nov 2020 - Aug 2024
    Burnaby, British Columbia, Ca
  • Ancilia Biosciences
    Investor
    Ancilia Biosciences Nov 2020 - Aug 2024
  • Rad Ai
    Investor
    Rad Ai Aug 2020 - Aug 2024
    San Francisco, California, Us
  • Auransa
    Investor
    Auransa Aug 2020 - Aug 2024
    Palo Alto, California, Us
  • Viscient Bio Inc
    Investor
    Viscient Bio Inc Aug 2020 - Aug 2024
    San Diego, California, Us
  • Insilico Medicine
    Investor
    Insilico Medicine Jul 2020 - Aug 2024
    Boston, Massachusetts, Us
  • Juvena Therapeutics
    Investor
    Juvena Therapeutics Jun 2020 - Aug 2024
    Palo Alto, Ca, Us
  • Pragma Bio
    Investor
    Pragma Bio May 2020 - Aug 2024
    South San Francisco, California, Us
  • Abalone Bio
    Investor
    Abalone Bio May 2020 - Aug 2024
    Emeryville, Ca, Us
  • Sentiar
    Investor
    Sentiar Apr 2020 - Aug 2024
    St. Louis, Missouri, Us
  • Atlas Space Operations, Inc.
    Investor
    Atlas Space Operations, Inc. Apr 2020 - Aug 2024
    Traverse City, Michigan, Us
  • Tarana Wireless, Inc.
    Investor
    Tarana Wireless, Inc. Mar 2020 - Aug 2024
    Milpitas, California, Us
  • Halo Industries, Inc.
    Investor
    Halo Industries, Inc. Mar 2020 - Aug 2024
    Santa Clara, Ca, Us
  • Gen1E Lifesciences Inc.
    Investor
    Gen1E Lifesciences Inc. Feb 2020 - Aug 2024
    Palo Alto, California, Us
  • Pathologywatch
    Investor
    Pathologywatch Dec 2020 - Jan 2024
    Salt Lake City, Ut, Us
    $150M M&A by Sonic Healthcare
  • Trials.Ai
    Investor
    Trials.Ai Dec 2020 - Jan 2023
    Princeton, New Jersey, Us
    Acquired by ZS Associates
  • Volumetric
    Investor
    Volumetric Jun 2020 - May 2022
    Houston, Texas, Us
    $400M M&A by 3D Systems
  • Massachusetts Institute Of Technology
    Research Assistant
    Massachusetts Institute Of Technology Nov 2017 - Mar 2019
    Cambridge, Ma, Us
    • Evaluated over $1 billion in VC-funded and bootstrapped entrepreneurial business ventures using 3 statement and excel-based financial models to forecast financing activity. The resulting analysis was used in MIT case studies.• Developed written briefs and reports examining bootstrapped startups, critically analyzing the deployment of innovation taxonomies in early-stage entrepreneurial ventures.• Research featured in the book: “Reimagining Innovation in Humanitarian Medicine” (Springer-Nature Press, 2018).
  • Harvard'S Belfer Center
    Research Assistant
    Harvard'S Belfer Center May 2017 - Jun 2018
    Cambridge, Ma, Us
    • Collaborated on the Science, Technology, and Globalization Project with Calestous Juma, Ph.D. focusing on the applications of cutting-edge technology to improve human health and economic development in 10+ African countries.• Researched affordable healthcare solutions and biomedical device applications in low-resource settings to improve the health outcomes for 50+ million people in sub-Saharan Africa. • Resulting research was published in the internationally-released scientific book “Bio-Based Material as Applicable, Accessible, and Affordable Healthcare Solutions” (2018).
  • Taubman Center For State & Local Government
    Research Assistant
    Taubman Center For State & Local Government Feb 2016 - Jul 2017
    Cambridge, Massachusetts, Us
    • Conducted portfolio analysis on the United States Agency for International Development (USAID) Development Innovation Ventures portfolio ($149M portfolio, 190+ investments, 5x ROI) with Nobel Laureate Economist, Michael Kremer, Ph.D. • Portfolio and investment analysis work published in the governmental report “Lower Bounds on the benefit-cost ratio and social rate of Return of USAID’s Development Innovation Ventures Portfolio”.

Krish W. Ramadurai Skills

Teamwork Research Spanish Data Analysis Microsoft Excel Microsoft Office Leadership Project Management Spss Python Powerpoint Microsoft Word Time Management Public Speaking Program Management Data Science Statistical Data Analysis Economic Development Nanobiotechnology Statistics Science Team Leadership Economic Data Analysis

Krish W. Ramadurai Education Details

  • University Of Oxford
    University Of Oxford
    Engineering Science
  • University Of Oxford
    University Of Oxford
    Nanotechnology For Medicine (Nanomedicine)
  • Washington University In St. Louis - Olin Business School
    Washington University In St. Louis - Olin Business School
    Mba
  • Harvard University
    Harvard University
    Biology
  • University Of Illinois Urbana-Champaign
    University Of Illinois Urbana-Champaign
    Integrative Biology And Economics With Chemistry Minor

Frequently Asked Questions about Krish W. Ramadurai

What company does Krish W. Ramadurai work for?

Krish W. Ramadurai works for Aix Ventures

What is Krish W. Ramadurai's role at the current company?

Krish W. Ramadurai's current role is Partner at AIX Ventures | Author.

What is Krish W. Ramadurai's email address?

Krish W. Ramadurai's email address is kr****@****ard.edu

What schools did Krish W. Ramadurai attend?

Krish W. Ramadurai attended University Of Oxford, University Of Oxford, Washington University In St. Louis - Olin Business School, Harvard University, University Of Illinois Urbana-Champaign.

What are some of Krish W. Ramadurai's interests?

Krish W. Ramadurai has interest in Poverty Alleviation, Science And Technology, Economic Empowerment, Health.

What skills is Krish W. Ramadurai known for?

Krish W. Ramadurai has skills like Teamwork, Research, Spanish, Data Analysis, Microsoft Excel, Microsoft Office, Leadership, Project Management, Spss, Python, Powerpoint, Microsoft Word.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.